Late Recurrence After Radical Resection of Esophageal Cancer
- PMID: 26552914
- DOI: 10.1007/s00268-015-3334-8
Late Recurrence After Radical Resection of Esophageal Cancer
Abstract
Background: Approximately 10-20 % of esophageal cancer patients in whom recurrence is diagnosed experience late recurrence beyond 2 years after esophagectomy. However, the risk of late recurrence is still unclear. The aim of this study was to identify the risk factors of late recurrence for appropriate postoperative surveillance.
Methods: A total of 447 patients underwent radical esophagectomy and reconstruction for esophageal cancer from 2005 to 2014. Patients who had recurrence beyond 2 years after esophagectomy were defined as the late recurrence group and the remaining patients with recurrence as the early recurrence group. A comparison of the clinicopathological factors and prognosis was performed between patients with early recurrence, late recurrence, and no recurrence.
Results: Recurrences were recognized in 117(26.2 %) of the 447 patients. Recurrence was diagnosed within 2 years after surgery in 103 patients (88.0 %) and after 2 years in 14 patients (12.0 %). Patients with late recurrence showed a favorable prognosis compared with those with early recurrence (P = 0.0131), and late recurrence was an independent factor associated with a favorable prognosis after recurrence (HR 0.199, P = 0.025). In the comparison between patients with late recurrence and those with no recurrence who had a minimal recurrence-free survival of 2 years, pathological lymph node metastasis at esophagectomy was found to be an independent predictor of late recurrence (HR 7.296, P = 0.043).
Conclusions: Pathological lymph node metastasis at esophagectomy is a risk factor of late recurrence for esophageal cancer, and a close, lifelong follow-up is recommended for such patients.
Similar articles
-
[Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].Ai Zheng. 2006 Jan;25(1):96-9. Ai Zheng. 2006. PMID: 16405760 Chinese.
-
Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy.World J Surg. 2007 May;31(5):1107-14. doi: 10.1007/s00268-006-0551-1. World J Surg. 2007. PMID: 17426905
-
Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?Ann Thorac Surg. 2009 Jun;87(6):1697-702. doi: 10.1016/j.athoracsur.2009.03.060. Ann Thorac Surg. 2009. PMID: 19463580
-
Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.Ann Thorac Surg. 2004 Oct;78(4):1177-83. doi: 10.1016/j.athoracsur.2004.02.068. Ann Thorac Surg. 2004. PMID: 15464466 Review.
-
[New trends in neoadjuvant chemoradiotherapy for locally-advanced esophageal cancer: esophagectomy--is it necessary?].Gan To Kagaku Ryoho. 2000 Nov;27(13):2016-22. Gan To Kagaku Ryoho. 2000. PMID: 11103231 Review. Japanese.
Cited by
-
Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.BMC Cancer. 2019 May 27;19(1):500. doi: 10.1186/s12885-019-5656-7. BMC Cancer. 2019. Retraction in: BMC Cancer. 2022 Apr 14;22(1):409. doi: 10.1186/s12885-022-09471-x. PMID: 31132995 Free PMC article. Retracted.
-
Analysis of risk factors for post-operative complications and prognostic predictors of disease recurrence following definitive treatment of patients with esophageal cancer from two medical centers in Northwest China.Exp Ther Med. 2017 Sep;14(3):2584-2594. doi: 10.3892/etm.2017.4835. Epub 2017 Jul 25. Exp Ther Med. 2017. PMID: 28962198 Free PMC article.
-
Clinical Features of Recurrence Pattern with Lung Metastasis After Radical Esophagectomy for Thoracic Esophageal Cancer.World J Surg. 2022 Sep;46(9):2270-2279. doi: 10.1007/s00268-022-06608-8. Epub 2022 Jun 16. World J Surg. 2022. PMID: 35708753
-
Computed tomography-based radiomics analysis to predict lymphovascular invasion in esophageal squamous cell carcinoma.Br J Radiol. 2022 Feb 1;95(1130):20210918. doi: 10.1259/bjr.20210918. Epub 2021 Dec 15. Br J Radiol. 2022. PMID: 34908477 Free PMC article.
-
Development and validation of a postoperative risk model for esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy.Front Med (Lausanne). 2025 Aug 4;12:1608313. doi: 10.3389/fmed.2025.1608313. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40832095 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical